INSM: Wutah pendapatan triwulanan Insmed Incorporated

Insmed Incorporated (INSM) - logo korporat

Expanding demand for pulmonary orphan drugs is driving growth, and the quarterly revenue change rate clearly demonstrates this momentum. The uniqueness of the therapy allows Insmed Incorporated (INSM) to maintain pricing power, although reliance on a few products and R&D costs create risks. Consequently, the indicator value reaches 268.20, capturing the current dynamics of the company's financial performance.

INSM Tambahing pendapatan triwulanan Insmed Inc (04.07.2022 - 20.11.2026)

Ringkesan rincian data analitis Insmed (INSM)

- rega saham lan target rega konsensus:
Analisis fundamental perusahaan:INSM - Insmed
Produk sing diprodhuksi insmed.com

Insmed Incorporated (INSM) ensures stable patient access to rare disease therapies through seamless logistics and redundant capacities. By analyzing the QoQ revenue growth rate, the efficiency of this infrastructure can be assessed via the dynamics of quarterly receipts. This metric measures the percentage change in sales volume relative to the previous period, filtering out market noise. The moderate trajectory of this indicator confirms the resilience of the business model and minimizes the risks of short-term capital overheating.

Pesaing langsung

Vertex Pharmaceuticals - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan ALNY (Alnylam Pharmaceuticals)|UTHR: Wutah pendapatan triwulanan|BioMarin Pharmaceutical Inc. (BMRN) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BridgeBio Pharma Inc|Wutah dodolan triwulanan BGM Group Ltd (BGM)|Wutah pendapatan kuartal marang kuartal cogentbio.com (COGT)|Wutah dodolan triwulanan Xeris Biopharma XERS|Wutah pendapatan triwulanan KROS (kerostx.com)|Wutah pendapatan triwulanan Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah pendapatan triwulanan|KMDA - Wutah pendapatan triwulanan|FULC (Fulcrum Corp) - Wutah dodolan triwulanan|ABEO (Abeona Therapeutics, Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PLRX|Wutah pendapatan kuartal marang kuartal APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah dodolan triwulanan|Gelteq Limited (GELS) - Tingkat wutah pendapatan sajrone kuartal|aytubio.com - Wutah pendapatan triwulanan|chemomab.com (CMMB) - Wutah dodolan triwulanan|SRXH: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal PLRZ (Polyrizon Ltd.)|Wutah dodolan triwulanan AEZS|CYTH: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal inozyme.com (INZY)|Wutah pendapatan triwulanan Reneo Pharmaceuticals Inc. (RPHM)|Wutah pendapatan triwulanan CSCI (Aeterna Zentaris)